Jefferies’s $50 target on DYN

DYN Dyne Therapeutics Inc

$16.2 → $50 (+208%) by Sep 2027

Buy · reiterates · said Sep 30, 2026 · 12-month default horizon

Open: judged on the close on Sep 30, 2027

The article this target came from

Jefferies reiterates Dyne Therapeutics stock rating on trial data

Investing.com · Sep 30, 2026

Jefferies reiterated a Buy rating and $50.00 price target on Dyne Therapeutics (NASDAQ:DYN) shares.

Jefferies’s track record → Dyne Therapeutics Inc →

A fact about what Jefferies published, as reported by Investing.com, not a recommendation from Dalsna Finance; Jefferies is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.